logo

Neurocrine Biosciences Inc (NBIX)



Trade NBIX now with
  Date
  Headline
9/14/2020 8:57:49 AM Neurocrine Reports Once-Daily ONGENTYS Available In US As Add-On Treatment For Patients With Parkinson's Disease
9/14/2020 6:52:48 AM William Blair Reiterates Neurocrine Biosciences Inc (NBIX) At Outperform
8/3/2020 4:04:44 PM Neurocrine Biosciences Q2 EPS $0.81 Vs. $0.54 Year Ago
6/16/2020 7:04:51 AM Neurocrine Biosciences, Takeda Announce Strategic Collaboration To Develop Early-to-mid-stage Psychiatry Pipeline
6/8/2020 11:02:20 AM Neurocrine Biosciences Reports Positive Data From Phase II Clinical Study Of Crinecerfont
5/11/2020 4:05:13 PM Neurocrine Biosciences Exercises Option To License Idorsia's Novel Treatment For Rare Pediatric Epilepsy
5/6/2020 4:07:20 PM Neurocrine Biosciences Q1 EPS $0.39 Vs. Loss $1.12 Year Ago